000			01538 a2200445 4500
005			20250512025732.0
264		0	_c19871007
008			198710s 0 0 eng d
022			_a0094-6176
024	7		_a10.1055/s-2007-1003492 _2doi
040			_aNLM _beng _cNLM
100	1		_aAcar, J
245	0	0	_aThrombolytic treatment in acute myocardial infarction. _h[electronic resource]
260			_bSeminars in thrombosis and hemostasis _cApr 1987
300			_a186-200 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAngioplasty, Balloon
650	0	4	_aAnistreplase
650	0	4	_aCoronary Vessels
650	0	4	_aDrug Administration Routes
650	0	4	_aFibrinolytic Agents _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInjections
650	0	4	_aInjections, Intravenous
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aPlasminogen _xtherapeutic use
650	0	4	_aPlasminogen Activators _xtherapeutic use
650	0	4	_aProspective Studies
650	0	4	_aResearch Design
650	0	4	_aStreptokinase _xadverse effects
650	0	4	_aTissue Plasminogen Activator _xtherapeutic use
650	0	4	_aUrokinase-Type Plasminogen Activator _xpharmacology
700	1		_aVahanian, A
700	1		_aMichel, P L
700	1		_aSlama, M
700	1		_aCormier, B
700	1		_aRoger, V
773	0		_tSeminars in thrombosis and hemostasis _gvol. 13 _gno. 2 _gp. 186-200
856	4	0	_uhttps://doi.org/10.1055/s-2007-1003492 _zAvailable from publisher's website
999			_c2963631 _d2963631